Are There Any Challenges in Targeting Type IV Collagen?
Despite its potential as a therapeutic target, there are several challenges in targeting type IV collagen. These include the redundancy and compensatory mechanisms within the ECM, the complexity of the tumor microenvironment, and the potential for side effects due to the widespread presence of type IV collagen in normal tissues. Developing specific and effective inhibitors without adverse effects remains a significant challenge.
